51 results
Page 2 of 3
S-4
c7ummaqihzj
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
8-K
EX-99.1
xaq2 sot4
7 May 21
Entry into a Material Definitive Agreement
7:09am
8-K
EX-10.1
n37i2a
7 May 21
Entry into a Material Definitive Agreement
7:09am
8-K
EX-2.1
bnif04j7 5699yi
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-2.1
j0lyelehmf7z4z2dn
7 May 21
Business combination disclosure
7:08am
425
EX-10.1
y447k44yu0e
7 May 21
Business combination disclosure
7:08am
425
EX-99.1
nl886
7 May 21
Business combination disclosure
7:08am
8-K
EX-99.1
85kf1izjmdfjttg46c
16 Nov 20
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
7:05am
DEF 14A
ttxdw7vs2fo5
9 Sep 20
Definitive proxy
4:00pm
PRE 14A
7cku7fzy sxovkvvr
10 Aug 20
Preliminary proxy
12:00am
10-K
o6lf89tf7 bm
29 Jun 20
Annual report
4:02pm
6-K
EX-99.1
rixz9vngr3oaw9x
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.2
pdh3mr4 jmn
1 Aug 18
Notice of Annual and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
nkbe5712am4d22uhj6c
27 Jun 18
Acasti Pharma Business Update for the Fourth Quarter and Fiscal 2018
5:01pm
6-K
EX-99.1
cq069 621gcjr
27 Apr 18
Acasti Pharma Appoints Donald Olds to its Board of Directors and Audit Committee
8:00am